Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Other Non Operating Income: 2020-2024

Historic Other Non Operating Income for Pharming Group N.V (PHAR) over the last 2 years, with Dec 2024 value amounting to -$169,000.

  • Pharming Group N.V's Other Non Operating Income was N/A to -$169,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $3.8 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2024, which is 636.56% up from last year.
  • As of Q4 2024, Pharming Group N.V's Other Non Operating Income stood at -$169,000, which was down 904.76% from $21,000 recorded in Q3 2024.
  • Over the past 5 years, Pharming Group N.V's Other Non Operating Income peaked at $5.1 million during Q2 2024, and registered a low of -$1.2 million during Q4 2022.
  • Moreover, its 2-year median value for Other Non Operating Income was -$74,000 (2024), whereas its average is $951,250.
  • As far as peak fluctuations go, Pharming Group N.V's Other Non Operating Income surged by 106.22% in 2021, and later plummeted by 3,850.00% in 2022.
  • Over the past 4 years, Pharming Group N.V's Other Non Operating Income (Quarterly) stood at $217,000 in 2020, then slumped by 113.82% to -$30,000 in 2021, then slumped by 3,850.00% to -$1.2 million in 2022, then reached -$169,000 in 2024.
  • Its Other Non Operating Income stands at -$169,000 for Q4 2024, versus $21,000 for Q3 2024 and $5.1 million for Q2 2024.